Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 61.32 |
| 開市 | 61.41 |
| 買盤 | 63.23 x 100 |
| 賣出價 | 63.41 x 100 |
| 今日波幅 | 61.37 - 64.25 |
| 52 週波幅 | 25.98 - 110.25 |
| 成交量 | |
| 平均成交量 | 1,989,049 |
| 市值 | 6.627B |
| Beta 值 (5 年，每月) | 0.68 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -5.45 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 93.88 |
ZacksCytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motley Fool2 Incredible Growth Stocks to Buy Right Now
These two biotech stocks could be big winners in the years ahead.
InvestorPlace7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Why do you want to consider biotech stocks? Simply, the narrative comes down to numbers and a possible rotation. First, the hard data supports bullishness in biotech stocks. According to Grand View Research, the underlying global industry reached a valuation of $1.55 trillion last year. Moving forward, experts project that the sector will expand at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. At the culmination point, the space may be worth $3.88 trillion. Second, a sector r
